Trial Profile
A DOSE ESCALATING STUDY TO DETERMINE THE TOLERABILITY AND PHARMACOKINETICS OF A SINGLE DOSE OF ANDROXAL IN HEALTHY VOLUNTEERS
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Enclomifene (Primary)
- Indications Male infertility
- Focus Pharmacokinetics
- Sponsors Repros Therapeutics
- 01 Nov 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Oct 2013 New trial record